Bank of America’s PharMerica Corporation PMC Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2017
Q4 | – | Sell |
-250,845
| Closed | -$7.35M | – | 7477 |
|
|
2017
Q3 | $7.35M | Sell |
250,845
-137,800
| -35% | -$3.86M | ﹤0.01% | 2818 |
|
|
2017
Q2 | $10.2M | Sell |
388,645
-3,351
| -0.9% | -$82.4K | ﹤0.01% | 2356 |
|
|
2017
Q1 | $9.17M | Buy |
391,996
+146,560
| +60% | +$3.62M | ﹤0.01% | 2471 |
|
|
2016
Q4 | $6.17M | Sell |
245,436
-29,738
| -11% | -$751K | ﹤0.01% | 2732 |
|
|
2016
Q3 | $7.72M | Buy |
275,174
+47,977
| +21% | +$1.23M | ﹤0.01% | 2460 |
|
|
2016
Q2 | $5.6M | Sell |
227,197
-32,148
| -12% | -$798K | ﹤0.01% | 2715 |
|
|
2016
Q1 | $5.74M | Sell |
259,345
-479,505
| -65% | -$12.8M | ﹤0.01% | 2649 |
|
|
2015
Q4 | $25.9M | Sell |
738,850
-650,171
| -47% | -$20.4M | 0.01% | 1437 |
|
|
2015
Q3 | $39.5M | Buy |
1,389,021
+407,974
| +42% | +$13.7M | 0.01% | 1134 |
|
|
2015
Q2 | $32.7M | Sell |
981,047
-97,271
| -9% | -$2.99M | 0.01% | 1075 |
|
|
2015
Q1 | $30.4M | Buy |
1,078,318
+202,471
| +23% | +$5.03M | 0.01% | 1087 |
|
|
2014
Q4 | $18.1M | Buy |
875,847
+185,474
| +27% | +$4.4M | 0.01% | 1458 |
|
|
2014
Q3 | $16.9M | Sell |
690,373
-4,461
| -0.6% | -$118K | 0.01% | 1526 |
|
|
2014
Q2 | $19.9M | Sell |
694,834
-15,287
| -2% | -$425K | 0.01% | 1410 |
|
|
2014
Q1 | $19.9M | Sell |
710,121
-145,871
| -17% | -$3.58M | 0.01% | 1298 |
|
|
2013
Q4 | $18.4M | Buy |
855,992
+106,766
| +14% | +$1.94M | 0.01% | 1385 |
|
|
2013
Q3 | $9.94M | Buy |
749,226
+129,507
| +21% | +$1.74M | ﹤0.01% | 1794 |
|
|
2013
Q2 | $8.59M | Buy |
+619,719
| New | +$8.78M | ﹤0.01% | 1846 |
|
Bank of America's PMC Position: Q4 2017 in Review
Bank of America sold out of PharMerica Corporation (PMC) in Q4 2017, closing a stake of 250,845 shares — an estimated $7.35M sold.
Bank of America first reported a position in PMC in Q2 2013 and held it in 18 quarters. The position peaked at $39.5M in Q3 2015. 0 funds tracked by Wall St. Rank hold PMC as of Q4 2017.
- Bank of America reported no remaining PharMerica Corporation position as of Q4 2017 after selling out during the quarter.
- Bank of America sold 250,845 PharMerica Corporation shares in Q4 2017, an estimated $7.35M.
- Bank of America first reported a position in PharMerica Corporation in Q2 2013 and held it in 18 quarters.
- Bank of America's PharMerica Corporation position peaked at $39.5M in Q3 2015.
- 0 funds tracked by Wall St. Rank held PharMerica Corporation as of Q4 2017.
Based on Bank of America's 13F filing for Q4 2017, filed 14 Feb 2018.